Author:
Falcoz Christine,Jenkins Julian M.,Bye Carole,Hardman Timothy C.,Kenney Kathy B.,Studenberg Scott,Fuder H.,Prince William T.
Subject
Pharmacology (medical),Pharmacology
Reference36 articles.
1. Safety and pharmacokinetics of amprenavir (141W94), a human immunodeficiency virus (HIV) type 1 protease inhibitor, following oral administration of single doses to HIV-infected adults;Sadler;Antimicrob Agents Chemother,1999
2. Single-dose pharmacokinetics of amprenavir, a human immunodeficiency virus (HIV) type 1 protease inhibitor, in subjects with normal or impaired hepatic function;Veronese;Antimicrob Agents Chemother,2000
3. In vitro antiviral activity of 141W94 (VX-478) in combination with other antiviral agents;Clair;Antivir Res,1996
4. Eron J Degruttola V Schock J et al The effects of amprenavir (APV) alone and in combination with ZDV/3TC, on HIV-1 levels in semen: a substudy of ACTG 347 [abstract 222] JanuaryFebruary 1999
5. Serini D Taulera O Lascoux C Antiviral activity of amprenavir (141W94) in combination with zidovudine/3TC in plasma and cerebrospinal fluid (CSF) in HIV-1 positive individuals [abstract 117] June 1998
Cited by
63 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献